tiprankstipranks
Venture Life Group PLC (GB:VLG)
LSE:VLG
Want to see GB:VLG full AI Analyst Report?

Venture Life (VLG) Price & Analysis

4 Followers

VLG Stock Chart & Stats

65.50 p
-1.00 p(-2.59%)
At close: 4:00 PM EST
65.50 p
-1.00 p(-2.59%)

Bulls Say, Bears Say

Bulls Say
De-risked Balance SheetThe sharp debt reduction to roughly £0.7m materially de-risks the capital structure, giving management flexibility to fund product development, support contract-manufacturing obligations, or weather demand swings without urgent refinancing. Low leverage improves strategic optionality over the next several quarters.
Diversified Revenue ModelA dual model of owned branded OTC products plus contract development and manufacturing provides complementary revenue streams. Manufacturing contracts deliver recurring B2B revenues that can smooth volatility from branded retail channels, improving resilience and long-term cash generation potential when commercial execution is consistent.
Improving ProfitabilityThe return to positive EBIT and a material increase in net income in 2025 signals improving operational performance and cost control. Sustained improvement would create a firmer earnings base to fund R&D, marketing and capacity, supporting durable margin recovery and stronger operating leverage versus prior years.
Bears Say
Negative Cash Flow In 2025The reversal to negative operating and free cash flow in 2025 breaks a prior multi-year pattern of solid cash conversion and suggests working-capital strain or one-off items. If cash generation remains weak, the company may need external funding or to draw reserves, constraining reinvestment and increasing execution risk over the medium term.
Revenue Volatility & Margin PressurePronounced revenue swings (down in 2024, rebound in 2025) coupled with flat gross profit dollars despite higher sales point to product-mix or margin erosion. This pattern undermines predictability of earnings and makes it harder to scale profitability unless underlying unit economics or mix are addressed.
Weak Historical Returns On EquityWeak or negative ROE in 2024 indicates the company has not consistently converted its sizeable equity base into profits. Even with low debt, persistently low returns suggest structural issues in profitability, pricing, or capital allocation that need resolution for investors to expect durable return improvement.

Venture Life News

VLG FAQ

What was Venture Life Group PLC’s price range in the past 12 months?
Venture Life Group PLC lowest share price was 40.00 p and its highest was 72.00 p in the past 12 months.
    What is Venture Life Group PLC’s market cap?
    Venture Life Group PLC’s market cap is £74.92M.
      When is Venture Life Group PLC’s upcoming earnings report date?
      Venture Life Group PLC’s upcoming earnings report date is Sep 30, 2026 which is in 154 days.
        How were Venture Life Group PLC’s earnings last quarter?
        Venture Life Group PLC released its earnings results on Mar 31, 2026. The company reported 0.027 p earnings per share for the quarter, beating the consensus estimate of N/A by 0.027 p.
          Is Venture Life Group PLC overvalued?
          According to Wall Street analysts Venture Life Group PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Venture Life Group PLC pay dividends?
            Venture Life Group PLC pays a Annually dividend of 0.04 p which represents an annual dividend yield of N/A. See more information on Venture Life Group PLC dividends here
              What is Venture Life Group PLC’s EPS estimate?
              Venture Life Group PLC’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Venture Life Group PLC have?
              Venture Life Group PLC has 121,828,070 shares outstanding.
                What happened to Venture Life Group PLC’s price movement after its last earnings report?
                Venture Life Group PLC reported an EPS of 0.027 p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.941%.
                  Which hedge fund is a major shareholder of Venture Life Group PLC?
                  Currently, no hedge funds are holding shares in GB:VLG
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Venture Life Group PLC

                    Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. It operates through Venture Life Brands and Customer Brands segments. The company offers neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance alertness, cognitive function, and mental performance in healthy brain; and Original Bioscalin to treat and prevent hair loss, hair thinning, and baldness. It also provides Fungal Nail Solution, which helps to treat and prevent fungal infections; and Fungal Nail Cleanser for the hygiene of hands and feet prone to fungal nail infections under the Myco Clear brand name. In addition, the company offers UltraDEX product for bad breath; Dently Dual Action, a mouthwash, which lifts and removes plaque and bacteria from the teeth and gums; and Procto-eze plus for anal irritation, including haemorrhoids condition. Further, it provides women healthcare products comprising vonalei bacterial vaginosis, a refreshing gel; vonalei Vaginal Atrophy, a vaginal cream; vonalei candidiasis, a soothing cream-gel for thrush; and vonalei intimate cleansing foam. Additionally, it offers Cleansing Foam, Cleansing Cream, and Serum under the Rosa calma brand name; and skincare ranges to hydrate, nourish, and recondition the skin, as well as to prevent the lines and wrinkles under the Lubatti Classic and the Lubatti Anti-age brand names. The company sells its products through a network of international partners, retail pharmacies, as well as grocery multiple retailers. Venture Life Group plc was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.

                    Venture Life (VLG) Earnings & Revenues

                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Allergy Therapeutics
                    Provexis
                    Shield Therapeutics
                    Haleon PLC

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks